Integra Lifesciences Holdings Corp reports results for the quarter ended in September - Earnings Summary

Integra LifeSciences Holdings

25/10/2023 14:32

* Integra Lifesciences Holdings Corp  IART.OQ  reported
quarterly
adjusted earnings of 76 cents​​ per share for the quarter ended
in September. The mean expectation of thirteen analysts for the
quarter was for earnings of 78 cents per share.
    * Revenue fell 0.2% to $384.42 million from a year ago;
analysts
expected $387.12 million. 
    * Integra Lifesciences Holdings Corp's reported EPS for the
quarter was 24 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Integra Lifesciences Holdings Corp shares had fallen
by 2.6%
this quarter and lost 33.7% so far this year.
    * The company reported quarterly net income of $19.5
million.
    * Wall Street's median 12-month price target for Integra
Lifesciences Holdings Corp is $46.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and 5 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 25 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.78           0.76           Missed
 Jun. 30 2023      0.57           0.71           Beat
 Mar. 31 2023      0.74           0.74           Met
 Dec. 31 2022      0.90           0.94           Beat